NCT05536570View on ClinicalTrials.gov

Whiplash-induced Thoracic Outlet Syndrome Treated With Botulinum Toxin.

PHASE4UnknownINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

October 15, 2022

Primary Completion Date

April 15, 2023

Study Completion Date

June 15, 2023

Conditions

Thoracic Outlet SyndromeWhiplash Injuries

Interventions

DRUG

IncobotulinumtoxinA 100 UNT

Scalene injection

Trial Locations (1)

B3P 1M3

Private Office, Halifax

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

MERZ PHARMA

UNKNOWN

lead

King, David, MD

INDIV